Corteva raises annual profit and sales forecast after strong first-half performance

Corteva (CTVA) significantly raised its full-year adjusted profit and sales forecasts, leading to a 6% surge in its shares, following strong first-half performance and an improved outlook for its Latin American business. The agrichemicals company now projects 2025 adjusted earnings between $3.00 and $3.20 per share, up from $2.70-$2.95, and full-year net sales in the range of $17.6 billion to $17.8 billion. This guidance raise was supported by better-than-expected Q2 results, with net sales climbing 5.6% to $6.46 billion and adjusted EPS reaching $2.20, both surpassing analyst estimates, and the company also plans to repurchase approximately $1 billion of shares during 2025.

Analysis

Corteva (CTVA) demonstrated robust operational performance in its second quarter, delivering results that materially beat consensus estimates and prompted a significant upgrade to its full-year guidance. Net sales grew 5.6% year-over-year to $6.46 billion, surpassing the $6.27 billion analyst forecast, driven by growth across all regions. The Crop Protection segment was a particular bright spot, with sales increasing 7.7%, which, according to Morningstar analysis, indicates that the industry headwind of inventory destocking is now behind the company. This operational strength translated to the bottom line, with adjusted EPS of $2.20 comfortably exceeding the $1.89 estimate. Reflecting this momentum and a strong outlook for its Latin American business in the second half, management raised its 2025 adjusted EPS forecast to a range of $3.00-$3.20 and its net sales guidance to $17.6-$17.8 billion. The company's confidence is further underscored by its plan to repurchase approximately $1 billion in shares during 2025, signaling a commitment to shareholder returns.

Key Decisions for Investors

• Given the strong earnings beat, upwardly revised guidance, and resolution of inventory destocking, investors may consider the 6% after-hours surge as fundamentally justified and view the current outlook as bullish.
• Monitor the performance of the Latin American business in the second half of the year, as management has explicitly identified it as a key driver for achieving the newly raised full-year targets.
• The planned $1 billion share buyback in 2025 provides a positive signal on valuation and should support the stock, making potential pullbacks an attractive entry point for position building.
• Investors should focus on future volume growth in the Crop Protection segment to confirm that the destocking cycle is truly complete, as this will be critical for sustaining long-term profit growth.